The Journal of Antibiotics · 2002 · 60 citations · 10 references
Life SciencesMicrobiologyPharmacologyDrug DiscoveryMycologyNatural Product BiosynthesisAntifungal AgentsAntifungal PharmacologyAntifungal ResistanceAntifungal TherapyFungal Natural Product BiosynthesisFungal Secondary MetabolitesAntifungal AntibioticsAntifungal PharmacodynamicsBotanical FungicidesNatural Antifungal CompoundsNew Antifungal AgentsNovel Antifungal Drug Development
Talaromyces flavus FKI-0076, a soil isolate, was found to produce compounds which reinforce the anti-Candida albicans activity of miconazole. Four structurally related compounds, a novel one, designated actofunicone, and the knowns deoxyfunicone, vermistatin and NG-012, were isolated from the culture broth by solvent extraction, ODS column chromatography and HPLC. The structure of actofunicone was elucidated as benzoic acid, 3,5-dimethoxy-2-[[4-oxo-6-(2-acetyloxy propyl)-4H-pyran-3-yl]carbonyl]-, methyl ester by various spectroscopic analyses including NMR experiments. These compounds potentiated the anti-C. albicans activity of miconazole, decreasing the IC50 value of miconazole from 19 microM to 1.6 approximately 3.7 microM in the presence of the funicones.
10
Dominique Sanglard, Karl Kuchler, Françoise Ischer et al. · Antimicrobial Agents and Chemotherapy · 1995 · 817 citations
H. Bart van den Hazel, Harald Pichler, Maria Adelaide do Valle Matta et al. · Journal of Biological Chemistry · 1999 · 156 citations · Full text